Related Experiment Videos
Formation of methylamines from ingested choline and lecithin
Summary
Choline supplements increase urinary trimethylamine (TMA), dimethylamine (DMA), and monomethylamine (MMA) excretion in humans. This suggests potential risks associated with high-dose choline and lecithin administration due to gut bacteria metabolism.
Area of Science:
- Biochemistry
- Human Physiology
- Microbiology
Background:
- Choline and lecithin are common dietary components.
- Physicians are increasingly using high-dose choline and lecithin for neurological conditions.
- Gut bacteria metabolize choline into trimethylamine (TMA), dimethylamine (DMA), and monomethylamine (MMA).
Purpose of the Study:
- To investigate the impact of oral choline and lecithin administration on methylamine excretion in humans and rats.
- To assess the potential health risks, including nitrosamine formation, linked to choline metabolism.
Main Methods:
- Healthy human subjects and rats were administered choline chloride, choline stearate, or lecithin.
- Urinary excretion of TMA, DMA, and MMA was measured.
- Methylamine contamination in tested compounds was analyzed.
Main Results:
- Choline chloride, choline stearate, and lecithin significantly increased urinary TMA, DMA, and MMA excretion in humans, with choline chloride showing the most pronounced effect.
- Choline chloride administration increased urinary TMA excretion in rats but did not affect DMA or MMA levels.
- Commercial lecithins and choline stearate were found to be contaminated with methylamines.
Conclusions:
- Oral administration of choline and lecithin leads to increased urinary methylamine excretion, primarily due to gut bacterial metabolism.
- Choline chloride exhibits the strongest effect on methylamine excretion.
- Contamination of supplements with methylamines can influence excretion levels, highlighting the importance of compound purity.